A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment

Autor: Laura Conforti, Michael J. Arnold, Hannah S. Newton, Trisha Wise-Draper, Julianne Qualtieri, Andras Balajthy, Ameet A. Chimote, Péter Hajdu
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Adult
Male
0301 basic medicine
Adenosine monophosphate
Adenosine
Adenosine A2 Receptor Agonists
Receptor
Adenosine A2A

T cell
Gene Expression
CD8-Positive T-Lymphocytes
Biochemistry
Article
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Cell Movement
Phenethylamines
Tumor Microenvironment
medicine
Humans
Cytotoxic T cell
Elméleti orvostudományok
Receptor
Molecular Biology
Cells
Cultured

Aged
Chemistry
Chemotaxis
Cell Biology
Orvostudományok
Middle Aged
Intermediate-Conductance Calcium-Activated Potassium Channels
medicine.disease
Head and neck squamous-cell carcinoma
Chemokine CXCL12
stomatognathic diseases
030104 developmental biology
medicine.anatomical_structure
Head and Neck Neoplasms
030220 oncology & carcinogenesis
Carcinoma
Squamous Cell

Cancer research
Female
CD8
medicine.drug
Popis: The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A 2A receptor (A 2A R) and suppression of KCa3.1 channels. We conducted three-dimensional chemotaxis experiments to elucidate the effect of adenosine on the migration of peripheral blood CD8 + T cells from head and neck squamous cell carcinoma (HNSCC) patients. The chemotaxis of HNSCC CD8 + T cells was reduced in the presence of adenosine, and the effect was greater on HNSCC CD8 + T cells than on healthy donor (HD) CD8 + T cells. This response correlated with the inability of CD8 + T cells to infiltrate tumors. The effect of adenosine was mimicked by an A 2A R agonist and prevented by an A 2A R antagonist. We found no differences in A 2A R expression, 3′,5′-cyclic adenosine monophosphate abundance, or protein kinase A type 1 activity between HNSCC and HD CD8 + T cells. We instead detected a decrease in KCa3.1 channel activity, but not expression, in HNSCC CD8 + T cells. Activation of KCa3.1 channels by 1-EBIO restored the ability of HNSCC CD8 + T cells to chemotax in the presence of adenosine. Our data highlight the mechanism underlying the increased sensitivity of HNSCC CD8 + T cells to adenosine and the potential therapeutic benefit of KCa3.1 channel activators, which could increase infiltration of these T cells into tumors.
Databáze: OpenAIRE